Australia Markets open in 9 hrs 8 mins

Roivant Sciences Ltd. (87S.F)

Frankfurt - Frankfurt Delayed price. Currency in EUR
Add to watchlist
6.22-0.15 (-2.35%)
At close: 01:52PM CEST
Currency in EUR

Valuation measures4

Market cap (intra-day) N/A
Enterprise value N/A
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)N/A
Enterprise value/revenue N/A
Enterprise value/EBITDA N/A

Trading information

Stock price history

Beta (5Y monthly) 1.26
52-week change 3N/A
S&P500 52-week change 3N/A
52-week high 38.78
52-week low 32.56
50-day moving average 37.40
200-day moving average 35.31

Share statistics

Avg vol (3-month) 319
Avg vol (10-day) 310
Shares outstanding 5725.42M
Implied shares outstanding 6N/A
Float 8162.14M
% held by insiders 150.41%
% held by institutions 150.74%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 3N/A
Trailing annual dividend yield 3N/A
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Currency in USD.

Fiscal year

Fiscal year ends 31 Mar 2022
Most-recent quarter (mrq)30 Sept 2022

Profitability

Profit margin 0.00%
Operating margin (ttm)-2,099.09%

Management effectiveness

Return on assets (ttm)-24.87%
Return on equity (ttm)-63.91%

Income statement

Revenue (ttm)50.42M
Revenue per share (ttm)0.07
Quarterly revenue growth (yoy)-10.40%
Gross profit (ttm)-413.81M
EBITDA N/A
Net income avi to common (ttm)-1.18B
Diluted EPS (ttm)-4.16
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)1.6B
Total cash per share (mrq)2.2
Total debt (mrq)477.3M
Total debt/equity (mrq)31.52
Current ratio (mrq)7.43
Book value per share (mrq)2.98

Cash flow statement

Operating cash flow (ttm)-857.68M
Levered free cash flow (ttm)-710.94M